Associating somatic gene mutations in glycophorin a with complex multifactorial diseases
AssigneeNova Southeastern University
InventorsStephen G. GRANT, Jean J. LATIMER
Life of this patent
Estimating the term…
Loading patent…
AssigneeNova Southeastern University
InventorsStephen G. GRANT, Jean J. LATIMER
Estimating the term…
In the detection of a complex multi-factorial disease, an MN blood group typing is performed on a first blood sample of a subject to be tested for a complex multifactorial disease, and on a second blood sample of a control subject having known phenotypes. Erythrocytes from the samples are isovolumetrically sphered, and M alleles and N alleles expressed on surfaces of erythrocyte cells of the first and second blood samples are labeled by contacting the blood samples with anti-M antibodies and anti-N antibodies associated with a marker. Labeled M alleles and labeled N alleles in the first and second blood samples are detected and quantified using the marker, in order to determine an incidence of somatic mutations in Glycophorin A of the patient. The incidence is compared with data pertaining to patients with a known complex multi-factorial disease, to diagnose the patient.
A method for detection of a complex multifactorial disease, comprising:
A method for diagnosis of a complex multifactorial disease in a patient, comprising:
A method for diagnosis of a complex multifactorial disease in a patient, comprising:
(canceled)
Dependencies are inferred from the claim text.